10x Genomics, Inc. (1KJ.F)

24,58 -1,45 (-5,57%) Ab 08:12AM CEST. Markt geöffnet.

10x Genomics, Inc.

6230 Stoneridge Mall Road
Pleasanton, CA 94588-3260
United States
925 401 7300
https://www.10xgenomics.com

Sektor(en): Healthcare
Branche: Health Information Services
Vollzeitmitarbeiter: 1.259

Leitende Angestellte

Name	Titel	Zahlen	Ausgeübt	Geburtsjahr
Dr. Serge Saxonov Ph.D.	Co-Founder, CEO & Director	867,27k	1,86M	1977
Dr. Benjamin J. Hindson Ph.D.	Co-Founder, President, Chief Scientific Officer & Director	579,7k	1,4M	1975
Mr. Justin J. McAnear	Chief Financial Officer	550,72k	N/A	1976
Mr. Eric S. Whitaker Esq.	Chief Legal Officer	576,94k	2,99M	1967
Mr. Michael Schnall-Levin	Founding Scientist & CTO	N/A	N/A	N/A
Ms. Cassie Corneau	Manager of Investor Relations and Strategic Finance	N/A	N/A	N/A
Ms. Rebecca Port	Chief People Officer	N/A	N/A	N/A

Die Beträge haben den Stand 31. Dezember 2023 und Kompensationswerte gelten für das letzte Geschäftsjahr bis zu diesem Datum. Der Lohn umfasst Gehalt, Boni usw. „Ausgeübt“ entspricht dem Wert von Optionen, die im Lauf des Geschäftsjahrs ausgeübt werden. Währung in EUR.

Beschreibung

10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in the America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium, chromium connect, and chromium controller instruments, microfluidic chips, slides, reagents, and other consumables products. Its single cell solutions runs on its chromium instruments, which include single cell gene expression for measuring gene activity and networks on a cell-by-cell basis; single cell gene expression flex; single cell immune profiling used to study the immune system; single cell Assay for Transposase Accessible Chromati (ATAC) solution to understand the epigenetic state; and single cell multiome ATAC + gene expression which enables simultaneous interrogation of both the RNA and chromatin accessibility, using ATAC in a single cell. The company also provides Visium platform which enables researchers to understand the spatial positions of biological analytes within tissues at high resolution; and Xenium platform for in situ analysis. It serves various academic, government, biopharmaceutical, biotechnology, and other institutions. The company was formerly known as 10X Technologies, Inc. and changed its name to 10x Genomics, Inc. in November 2014. 10x Genomics, Inc. was incorporated in 2012 and is headquartered in Pleasanton, California.

Corporate Governance

10x Genomics, Inc.s ISS Governance QualityScore, Stand 29. April 2024, lautet 10. Die grundlegenden Scores sind Audit: 2, Vorstand: 6, Shareholderrechte: 10, Kompensation: 10.

Corporate-Governance-Bewertungen von Institutional Shareholder Services (ISS). Die Werte geben den Zehntelwert im Verhältnis zum Index oder zur Region an. Ein Zehntelwert von 1 zeigt geringeres Governance-Risiko, 10 höheres Governance-Risiko.